Biocompatible hydrogel of cross-linked sodium hyaluronate obtained by biofermentation and highly purified. The product is a sterile and apirogenic injectable hydrogel, with low level of endotoxins.
TrHCROSS is intended to be injected intra-articularly in the synovial space of the knee as viscosupplementation medium for synovial fluid when its viscosity has been reduced due to osteoarthritis process in patients who have not responded adequately to conservative non-pharmacological therapy and simple analgesics.
Due to its rheological and physicochemical properties:
+ Reduces the pain and increases the functionality of the affected joint.
+ Provides a lubricant and shock-absortion effect on the affected joint.
+ Improves the quality of life of the patient
TrHCROSS 2% is supplied in a graduated, pre-filled and disposable Type I glass sterile syringe, containing 4.4 mL of solution, ready to use.
Do you want to know more?
Fill in the following details and one of our sales representatives will contact you shortly.